Cite
HARVARD Citation
Reding, M. et al. (2017). Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII. Journal of thrombosis and haemostasis. pp. 411-419. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reding, M. et al. (2017). Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII. Journal of thrombosis and haemostasis. pp. 411-419. [Online].